The National Health Insurance Civilian Surveillance Alliance yesterday questioned the legitimacy of a certification for pharmaceutical manufacturers after a majority of the manufacturers that were required by the Food and Drug Administration (FDA) to re-file bioequivalence testing (BE) reports for changes made to their products were awarded PIC/S GMP or GMP certification.
BE testing is conducted to ensure that a generic drug delivers the same therapeutic effect as a reference brand-name pharmaceutical.
In response, the agency said that the changes to the drugs were “legitimate” and have no negative impact on drug safety.
Photo: Wei Yi-chia, Taipei Times
At the end of August, the health insurance watchdog held a press conference to report that as many as 3,841 drug products failed to comply with pharmaceutical regulations after making changes to package inserts, packaging and the excipients used in drugs without seeking re-approval by the regulator.
In response, the agency promised to hold risk assessment meetings to evaluate the drugs that had been altered.
This month, the agency announced that 33 out of 3,841 generic drug products would need to be tested for their bioequivalence with brand-name medicines, with 21 more to be examined.
The group found that 10 of the 11 drug manufacturers that produce the 33 drugs are PIC/S GMP (Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, or the guide to Good Manufacturing Practice for medicinal products) or GMP certified.
“The government has required all pharmaceutical manufacturers to be PIC/S-certified by the end of next year, after which those without will not be permitted to make or sell drugs in Taiwan,” alliance spokeswoman Eva Teng (滕西華) said.
“However, the 10 manufacturers account for 15.8 percent of the 57 PIC/S GMP-certified manufacturers in the country. This makes us concerned that the certification does not guarantee drug quality,” Teng added.
The lack of BE testing reports for drugs that have been altered is a major problem, the group said.
“Changing the excipient, the diluent or the vehicle of a drug could decrease its therapeutic effect,” alliance convener Huang Sue-ying (黃淑英) said, adding that the agency should have ordered that the 33 drug products be pulled off shelves immediately after the announcement this month.
“The agency asked doctors to look for substitutes as soon as possible, and said that the drugs were without health risks,” she said.
FDA official Chi Jo-feng (祁若鳳) said that the PIC/S GMP certificate would not be revoked unless the violations are “grave,” such as producing counterfeit drugs, adding that the drugs were not withdrawn from the market immediately because some patients need time to switch to a new drug.
The agency updated the list in a statement yesterday, announcing the final result of the assessment for the need of BE testing on a total of 54 drugs (including the 33 announced earlier), which said that only nine of the 54 would need to redo BE testing.
One of the 33 drugs required to be tested this month was made exempt because the manufacturer had subsequently handed in relevant documents, while several others decided to revert to the original formula or simply give up the permit for the drug and had their products pulled off shelves, an FDA official said.
A decision to describe a Chinese Ministry of Foreign Affairs statement on Singapore’s Taiwan policy as “erroneous” was made because the city-state has its own “one China policy” and has not followed Beijing’s “one China principle,” Deputy Minister of Foreign Affairs Tien Chung-kwang (田中光) said yesterday. It has been a longstanding practice for the People’s Republic of China (PRC) to speak on other countries’ behalf concerning Taiwan, Tien said. The latest example was a statement issued by the PRC after a meeting between Singaporean Prime Minister Lawrence Wong (黃循財) and Chinese President Xi Jinping (習近平) on the sidelines of the APEC summit
The Taipei Zoo on Saturday said it would pursue legal action against a man who was filmed climbing over a railing to tease and feed spotted hyenas in their enclosure earlier that day. In videos uploaded to social media on Saturday, a man can be seen climbing over a protective railing and approaching a ledge above the zoo’s spotted hyena enclosure, before dropping unidentified objects down to two of the animals. The Taipei Zoo in a statement said the man’s actions were “extremely inappropriate and even illegal.” In addition to monitoring the hyenas’ health, the zoo would collect evidence provided by the public
A road safety advocacy group yesterday called for reforms to the driver licensing and retraining system after a pedestrian was killed and 15 other people were injured in a two-bus collision in Taipei. “Taiwan’s driver’s licenses are among the easiest to obtain in the world, and there is no mandatory retraining system for drivers,” Taiwan Vision Zero Alliance, a group pushing to reduce pedestrian fatalities, said in a news release. Under the regulations, people who have held a standard car driver’s license for two years and have completed a driver training course are eligible to take a test
Taiwan’s passport ranked 34th in the world, with access to 141 visa-free destinations, according to the latest update to the Henley Passport Index released today. The index put together by Henley & Partners ranks 199 passports globally based on the number of destinations holders can access without a visa out of 227, and is updated monthly. The 141 visa-free destinations for Taiwanese passport holders are a slight decrease from last year, when holders had access to 145 destinations. Botswana and Columbia are among the countries that have recently ended visa-free status for Taiwanese after “bowing to pressure from the Chinese government,” the Ministry
RSS